Skip to Content
Merck

[Molybdocene dichloride as an antitumor agent (author's transl)].

Zeitschrift fur Naturforschung. Section C, Biosciences (1979-12-01)
P Köpf-Maier, M Leitner, R Voigtländer, H Köpf
PMID161840
ABSTRACT

The antitumor activity of molybdocene dichloride is tested against Ehrlich ascites tumor in CF1 mice. The application of 75 of 100 mg/kg 24 h after transplantation achieves 100% tumor inhibition until day 30. Following the d0 and d1 metallocene dichlorides of titanium and vanadium, molybdocene dichloride is the first analogous d2 system revealing similar antineoplastic properties.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Bis(cyclopentadienyl)molybdenum(IV) dichloride, 95%